Coronavirus (COVID-19) Update: FDA Takes Action to Help Facilitate Timely Development of Safe, Effective COVID-19 Vaccines | FDA

Coronavirus (COVID-19) Update: FDA Takes Action to Help Facilitate Timely Development of Safe, Effective COVID-19 Vaccines | FDA

FDA Takes Action to Help Facilitate Timely Development of Safe, Effective COVID-19 Vaccines

On June 30, 2020, the FDA took important action to help facilitate the timely development of safe and effective vaccines to prevent COVID-19 by providing guidance with recommendations for those developing COVID-19 vaccines for the ultimate purpose of licensure. The guidance, which reflects advice the FDA has been providing over the past several months to companies, researchers, and others, describes the agency’s current recommendations regarding the data needed to facilitate the manufacturing, clinical development, and approval of a COVID-19 vaccine.

Read the news release

Related links: Guidance: Development and Licensure of Vaccines to Prevent COVID-19 Coronavirus (COVID-19) | CBER-Regulated Biologics